Volitionrx (VNRX) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Volitionrx (VNRX) over the last 8 years, with Q3 2025 value amounting to -$1.5 million.
- Volitionrx's Enterprise Value rose 7688.97% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 7688.97%. This contributed to the annual value of -$4.5 million for FY2024, which is 7936.9% up from last year.
- Per Volitionrx's latest filing, its Enterprise Value stood at -$1.5 million for Q3 2025, which was up 7688.97% from -$3.5 million recorded in Q2 2025.
- Volitionrx's 5-year Enterprise Value high stood at -$1.5 million for Q3 2025, and its period low was -$33.1 million during Q1 2021.
- For the 5-year period, Volitionrx's Enterprise Value averaged around -$14.6 million, with its median value being -$12.8 million (2024).
- As far as peak fluctuations go, Volitionrx's Enterprise Value crashed by 8950.79% in 2023, and later soared by 7936.9% in 2024.
- Quarter analysis of 5 years shows Volitionrx's Enterprise Value stood at -$20.8 million in 2021, then skyrocketed by 45.11% to -$11.4 million in 2022, then plummeted by 89.51% to -$21.6 million in 2023, then surged by 79.37% to -$4.5 million in 2024, then soared by 66.09% to -$1.5 million in 2025.
- Its Enterprise Value stands at -$1.5 million for Q3 2025, versus -$3.5 million for Q2 2025 and -$3.9 million for Q1 2025.